GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PMGC Holdings Inc (NAS:ELAB) » Definitions » Long-Term Debt

ELAB (PMGC Holdings) Long-Term Debt : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is PMGC Holdings Long-Term Debt?

PMGC Holdings's Long-Term Debt for the quarter that ended in Sep. 2024 was $0.00 Mil.


PMGC Holdings Long-Term Debt Historical Data

The historical data trend for PMGC Holdings's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PMGC Holdings Long-Term Debt Chart

PMGC Holdings Annual Data
Trend Dec21 Dec22 Dec23
Long-Term Debt
- - -

PMGC Holdings Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

PMGC Holdings  (NAS:ELAB) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


PMGC Holdings Long-Term Debt Related Terms

Thank you for viewing the detailed overview of PMGC Holdings's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


PMGC Holdings Business Description

Traded in Other Exchanges
N/A
Address
120 Newport Center Drive, Suite. 250, Newport Beach, CA, USA, 92660
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.